{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Hahn EA"],"funding":["Intramural NIH HHS","NCI NIH HHS"],"pagination":["149-161"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC11329347"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["120(1)"],"pubmed_abstract":["<h4>Purpose</h4>Our purpose was to evaluate the measurement properties of patient-reported outcome (PRO) measures used in the ongoing RadComp pragmatic randomized clinical trial (PRCT).<h4>Methods and materials</h4>The deidentified and blinded data set included 774 English-speaking female participants who completed their 6-month posttreatment assessment. Eleven PRO measures were evaluated, including the Trial Outcome Index from the Functional Assessment of Cancer Therapy-Breast (FACT-B), Satisfaction with Breast Cosmetic Outcomes, the BREAST-Q, and selected Patient-Reported Outcomes Measurement Information System (PROMIS) measures. PROs were measured at 3 timepoints: baseline, completion of radiation therapy (RT), and 6 months post-RT. Ten variables were used as validity anchors. Pearson o"],"journal":["International journal of radiation oncology, biology, physics"],"pubmed_title":["Validation of Patient-Reported Outcomes in Patients With Nonmetastatic Breast Cancer Receiving Comprehensive Nodal Irradiation in the RadComp Trial."],"pmcid":["PMC11329347"],"funding_grant_id":["P30 CA008748","K08 CA252640","Z99 CA999999"],"pubmed_authors":["Taghian AG","Chen PY","Algan O","Dover L","Siegal AM","Stephenson L","Willoughby T","Romesser PB","Ky B","Croog VJ","Patel S","Sturgeon JD","Halyard MY","Hamstra DA","Lin LL","Prior F","Katz S","Medek SA","Hong JJ","Novick KL","DeBlois D","McCormick B","Bradley JA","Mah D","Haffty BG","Weksberg DC","MacDonald SM","Lockney N","Lin H","Manke H","Kunaprayoon DK","Corbin KS","Yu J","Joyner MM","Hahn EA","Parikh D","McAvoy SA","Smith BD","Kang KH","Manu Mysore","Hencek C","Braunstein LZ","Hong L","Bhooshan N","Wong T","Fagundes M","Vyfhuis MAL","Berman AT","Driscoll A","Paganetti H","Powell SN","Gewanter RM","Yu A","Narezkina A","Mitchell SA","Vela AM","Zielan RR","Dong L","Bennouna J","Baas C","Croley R","Konski AA","Chen Y","Bekelman JE","McDonald A","Remmes NB","Li H","Hyde C","Ohri N","Chen K","Wilcox N","Rutenberg M","Chen CC","Mueller BA","Mihalcik SA","Wright JL","Dvorak T","Lu HL","Gilbo P","Seibert T","Phreaner N","Paulus R","Jackson A","Akthar AS","Balanescu D","Mychalczak B","Zou W","Urbanic JJ","Majithia L","Panoff J","Mayadev JS","LaPlant Q","McGee LA","Yue NJ","Patel AN","Feriozzi A","Depauw N","Akhter N","Liang X","Zoberi I","Wilson J","Jagsi R","Guttman DM","Zeidan O","Benhabib S","Godishala A","Pang D","Mailhot RB","Lyons J","Rao AD","Moiseenko V","Cella D","Walker AJ","Cardan RA","Bernstein M","Kolker JD","Harris EE","Meier T","Donisan T","Vallabhaneni S","Bakhoum SF","Freedman GM","Gelblum DY","Tabakha S","Bosch W","Stutz MD","Wilkinson JB","Dalton A","Lee C","Cheng R","Cuaron JJ","Boggs DH","Chen ET","Mitchell J","Godette KD","Henson CE","Poenisch F","Daugherty EC","Mann J","Rash D","Shumway DA","Suero-Abreu G","Stinson S","Taunk NK","Kesslering CM","Dadkhah H","Mishra MV","Wang CJ","Strom EA","Pugh SL","Barron DA","Ahmad N","Wang P","Rosen LR","Goyal S","Hoffman KE","Cahlon O","Parhar PK","Rudra S","Yan ES","Kim JN","Gillespie EF","Terry Wu","Ho A","Amelia Rodrigues M","Thukral AD","Pankuch M","Soto D","Feigenberg SJ","Yashar C","Jimenez RB","Devisetty K","Study Group Investigators:","Shepherd AF","Mendenhall N","Roth O'Brien D","Pafundi DH","Zinovoy M","Nichols EM","Daniella Dang P","Ding X","Mutter RW","Xu A","Dilworth JT","Straube W","Reza N","Mitchell MP","Kim HK","Choi JI","Mascia A","Wang WA","Khan A","Nowak Choi KA","Chawla A","Smith K","Tsai HK","Fang LC","Schupak KD","Langen KM"],"additional_accession":[]},"is_claimable":false,"name":"Validation of Patient-Reported Outcomes in Patients With Nonmetastatic Breast Cancer Receiving Comprehensive Nodal Irradiation in the RadComp Trial.","description":"<h4>Purpose</h4>Our purpose was to evaluate the measurement properties of patient-reported outcome (PRO) measures used in the ongoing RadComp pragmatic randomized clinical trial (PRCT).<h4>Methods and materials</h4>The deidentified and blinded data set included 774 English-speaking female participants who completed their 6-month posttreatment assessment. Eleven PRO measures were evaluated, including the Trial Outcome Index from the Functional Assessment of Cancer Therapy-Breast (FACT-B), Satisfaction with Breast Cosmetic Outcomes, the BREAST-Q, and selected Patient-Reported Outcomes Measurement Information System (PROMIS) measures. PROs were measured at 3 timepoints: baseline, completion of radiation therapy (RT), and 6 months post-RT. Ten variables were used as validity anchors. Pearson o","dates":{"release":"2024-01-01T00:00:00Z","publication":"2024 Sep","modification":"2026-06-02T09:13:06.615Z","creation":"2024-11-09T11:00:27.959Z"},"accession":"S-EPMC11329347","cross_references":{"pubmed":["38739047"],"doi":["10.1016/j.ijrobp.2024.03.020"]}}